Marks is the third top official to leave the FDA this year. Patrizia Cavazzoni, the FDA’s drug chief, resigned in early January and said her family had taken a “backseat” while she worked.

The abrupt resignation announcement that came late on Friday, March 28, from Peter Marks, who heads the U.S. FDA's Center for Biologics Evaluation and Research, has sent reverberations throughout ...

Peter Marks, who has served as director of the FDA’s Center for Biologics Evaluation and Research since 2016, hosts a public workshop on March 3, 2020. Ermath, Michael. (2020).

Dr. Peter Marks, then-director of the FDA's Center for Biologics Evaluation and Research, testifies on Capitol Hill, on May 11, 2021.Jim Lo Scalzo / Pool via AP file ...

Dr. Peter Marks, director of the agency’s Center for Biologics Evaluation and Research, was given the choice to resign or be fired. Marks’ resignation takes effect April 5.

FDA head wanted Vinay Prasad back at the Center for Biologics Evaluation and Research, and some pharma firms are taking a hit ...

Dr. Peter Marks sent a letter to Acting FDA Commissioner Sara Brenner on Friday saying that he would resign and retire by April 5 as director of the Center for Biologics Evaluation and Research.

Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, told reporters late Friday that the reactions had been reported in more than one state besides Alaska and that ...

Dr. Peter Marks, director of the agency’s Center for Biologics Evaluation and Research, was given the choice to resign or be fired. Marks’ resignation takes effect April 5. The news of Marks’ forced ...